Key facts
- An experimental pill was tested in patients with six difficult-to-treat cancers.
- The pill showed potential in shrinking tumors.
- Tumor shrinkage was observed in approximately one-third of patients.
This early trial suggests a potential new therapeutic approach for several challenging cancer types. Further research and larger trials will be necessary to confirm these findings and assess the pill's efficacy and safety.